OBJECTIVE: Chronic benzodiazepine (BZD) use is widespread and linked with adverse effects. There is consensus concerning the importance of initiating BZD as a crucial moment. Nevertheless specific research in this field is lacking. This paper addresses the views of GPs on why they start prescribing BZDs to first-time users. DESIGN: Qualitative study with five focus groups analysed using a systematic content analysis. SETTING: Regions of Ghent and Brussels in Belgium. SUBJECTS: A total of 35 general practitioners. MAIN OUTCOME MEASURE: The GPs' perspective on their initiating of BZD prescribing. RESULTS: GPs reported that they are cautious in initiating BZD usage. At the same time, GPs feel overwhelmed by the psychosocial problems of their patients. They show empathy by prescribing. They feel in certain situations there are no other solutions and they experience BZDs as the lesser evil. They admit to resorting to BZDs because of time restraint and lack of alternatives. GPs do not perceive the addictive nature of BZD consumption as a problem with first-time users. GPs do not specifically mention patients' demand as an element for starting. CONCLUSION: The main concern of GPs is to help the patient. GPs should be aware of the addictive nature of BZD even in low doses and a non-pharmacological approach should be seen as the best first approach. If GPs decide to prescribe a BZD they should make plain to the patient that the medication is only a "temporary" solution with clear agreements with regard to medication withdrawal.
OBJECTIVE: Chronic benzodiazepine (BZD) use is widespread and linked with adverse effects. There is consensus concerning the importance of initiating BZD as a crucial moment. Nevertheless specific research in this field is lacking. This paper addresses the views of GPs on why they start prescribing BZDs to first-time users. DESIGN: Qualitative study with five focus groups analysed using a systematic content analysis. SETTING: Regions of Ghent and Brussels in Belgium. SUBJECTS: A total of 35 general practitioners. MAIN OUTCOME MEASURE: The GPs' perspective on their initiating of BZD prescribing. RESULTS: GPs reported that they are cautious in initiating BZD usage. At the same time, GPs feel overwhelmed by the psychosocial problems of their patients. They show empathy by prescribing. They feel in certain situations there are no other solutions and they experience BZDs as the lesser evil. They admit to resorting to BZDs because of time restraint and lack of alternatives. GPs do not perceive the addictive nature of BZD consumption as a problem with first-time users. GPs do not specifically mention patients' demand as an element for starting. CONCLUSION: The main concern of GPs is to help the patient. GPs should be aware of the addictive nature of BZD even in low doses and a non-pharmacological approach should be seen as the best first approach. If GPs decide to prescribe a BZD they should make plain to the patient that the medication is only a "temporary" solution with clear agreements with regard to medication withdrawal.
Authors: Rolf van Hulten; Arnold B Bakker; Aart C Lodder; K Bart Teeuw; Albert Bakker; Hubert G Leufkens Journal: Soc Sci Med Date: 2003-03 Impact factor: 4.634
Authors: Y Dündar; A Boland; J Strobl; S Dodd; A Haycox; A Bagust; J Bogg; R Dickson; T Walley Journal: Health Technol Assess Date: 2004-06 Impact factor: 4.014
Authors: Wim Gorgels; Richard Oude Voshaar; Audrey Mol; Eloy Van De Lisdonk; Jan Mulder; Henk Van Den Hoogen; Anton Van Balkom; Marinus Breteler; Frans Zitman Journal: Scand J Prim Health Care Date: 2008 Impact factor: 2.581